(Q44832395)

6 December 2017

title

p53 and hepatoma-derived growth factor expression and their clinicopathological association with Ewing family tumour (English)

1 reference

6 December 2017

Yang Yang

1

1 reference

6 December 2017

Tiantian Zhen

2

1 reference

6 December 2017

Fenfen Zhang

3

1 reference

6 December 2017

Sujuan Dai

4

1 reference

6 December 2017

Lili Kang

5

1 reference

6 December 2017

Yingjie Liang

6

1 reference

6 December 2017

Ling Xue

7

1 reference

6 December 2017

Anjia Han

8

1 reference

6 December 2017

language of work or name

English

0 references

publication date

26 September 2013

1 reference

Journal of Clinical Pathology

6 December 2017

published in

1 reference

6 December 2017

volume

67

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

235-242

1 reference

Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing family tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

A new member of the ETS family fused to EWS in Ewing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing's sarcoma: correlation with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing Family Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

The expression and prognostic significance of hepatoma-derived growth factor in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

p53 negatively regulates the hepatoma growth factor HDGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201705

10.1136/JCLINPATH-2013-201705

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference